NO20064983L - Enterisk opploselig belegg til oralt inntakbare substrater - Google Patents

Enterisk opploselig belegg til oralt inntakbare substrater

Info

Publication number
NO20064983L
NO20064983L NO20064983A NO20064983A NO20064983L NO 20064983 L NO20064983 L NO 20064983L NO 20064983 A NO20064983 A NO 20064983A NO 20064983 A NO20064983 A NO 20064983A NO 20064983 L NO20064983 L NO 20064983L
Authority
NO
Norway
Prior art keywords
orally ingestible
soluble coating
ingestible substrates
enteric soluble
substrates
Prior art date
Application number
NO20064983A
Other languages
English (en)
Norwegian (no)
Inventor
Kurt A Fegely
Simon Tasker
Lawrence Martin
Original Assignee
Bpsi Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bpsi Holdings Inc filed Critical Bpsi Holdings Inc
Publication of NO20064983L publication Critical patent/NO20064983L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
NO20064983A 2004-03-31 2006-10-31 Enterisk opploselig belegg til oralt inntakbare substrater NO20064983L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55793404P 2004-03-31 2004-03-31
PCT/US2005/009713 WO2005097082A1 (en) 2004-03-31 2005-03-24 Enteric coatings for orally ingestible substrates

Publications (1)

Publication Number Publication Date
NO20064983L true NO20064983L (no) 2006-12-19

Family

ID=35124814

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064983A NO20064983L (no) 2004-03-31 2006-10-31 Enterisk opploselig belegg til oralt inntakbare substrater

Country Status (13)

Country Link
US (1) US7709025B2 (ja)
EP (1) EP1729742A1 (ja)
JP (1) JP2007530683A (ja)
KR (1) KR20070007868A (ja)
CN (1) CN1938006B (ja)
AU (1) AU2005231145B8 (ja)
BR (1) BRPI0508075A (ja)
CA (1) CA2555114C (ja)
IL (1) IL177225A0 (ja)
MX (1) MXPA06010488A (ja)
NO (1) NO20064983L (ja)
WO (1) WO2005097082A1 (ja)
ZA (1) ZA200606744B (ja)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06002657A (es) 2003-09-09 2006-06-05 Fumapharm Ag Uso de derivados de acido fumarico para el tratamiento de insuficiencia cardiaca y asma.
WO2006037342A2 (en) 2004-10-08 2006-04-13 Aditech Pharma Ab Controlled release pharmaceutical compositions comprising a fumaric acid ester
WO2007092717A1 (en) * 2006-02-07 2007-08-16 Fmc Corporation Latex or pseudolatex compositions coatings and coating processes
US8968799B2 (en) * 2006-09-01 2015-03-03 Rise-N-Shine L.L.C. Time delayed release mechanism for energizing composition and method of use
PT2139467T (pt) * 2007-02-08 2016-12-16 Biogen Ma Inc Neuroproteção em doenças desmielinizantes
DE102007039772A1 (de) 2007-08-22 2009-02-26 Cavis Microcaps Gmbh Mikrokapsel und Verfahren zu deren Herstellung
US20090136650A1 (en) * 2007-09-18 2009-05-28 Viva Pharmaceuticals Inc. Enteric coatings for orally ingestible compositions
US20090074944A1 (en) * 2007-09-18 2009-03-19 Viva Pharmaceuticals Inc. Enteric coatings for orally ingestible compositions
PL2564839T3 (pl) 2009-01-09 2016-11-30 Preparat farmaceutyczny obejmujący jeden lub więcej estrów kwasu fumarowego i matrycę erozyjną
GB2483815B (en) 2009-05-18 2013-12-25 Sigmoid Pharma Ltd Composition comprising oil drops
AU2011290958B2 (en) * 2010-08-18 2014-06-19 Evonik Operations Gmbh Gastric resistant pharmaceutical or nutraceutical formulation comprising one or more salts of alginic acid
WO2012059937A1 (en) * 2010-11-01 2012-05-10 Abbott Healthcare Private Limited Modifies release pharmaceutical compositons for nsaids
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
AU2013255666A1 (en) * 2012-05-03 2014-11-20 Cipla Limited Antiretroviral composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
EP2968178B1 (en) * 2013-03-15 2019-10-09 Inspirion Delivery Sciences LLC Pharmaceuticals comprising a ph-dependent component and ph-raising agent
GB201319792D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
KR102287342B1 (ko) 2014-01-21 2021-08-06 비피에스아이 홀딩스, 엘엘씨. 중쇄 글리세라이드를 함유하는 속방형 필름 코팅물 및 이를 코팅한 기질
US20150238514A1 (en) * 2014-02-21 2015-08-27 William Armstrong Protective Supplement Configuration
KR102392313B1 (ko) * 2014-09-03 2022-05-02 라이온 가부시키가이샤 코팅 제제 및 그 제조 방법
JP6716582B2 (ja) 2014-11-07 2020-07-01 サブリミティ・セラピューティクス・リミテッドＳｕｂｌｉｍｉｔｙ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ シクロスポリンを含む組成物
WO2017027778A1 (en) 2015-08-13 2017-02-16 Temple University-Of The Commonwealth System Of Higher Education Calcium alginate dosage formulations, and methods of making and using thereof
ES2894362T3 (es) 2015-10-22 2022-02-14 Arjuna Natural Private Ltd Un proceso para mejorar la bioactividad de los extractos de ashwagandha
US20170119680A1 (en) 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
GB201607548D0 (en) * 2016-04-29 2016-06-15 Univ Central Lancashire Solid dosage form
WO2020161653A2 (en) * 2019-02-07 2020-08-13 Benny Antony Mustard extract enriched with sinigrin having increased bioactivity and bioavailability of allyl isothiocyanate
WO2023111118A1 (en) * 2021-12-17 2023-06-22 Dsm Ip Assets B.V. New coating system (i)

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123403A (en) 1977-06-27 1978-10-31 The Dow Chemical Company Continuous process for preparing aqueous polymer microsuspensions
US4330338A (en) 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4308251A (en) 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
US4525345A (en) * 1981-12-24 1985-06-25 Verex Laboratories, Inc. Constant order release, solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
US4502888A (en) 1982-12-13 1985-03-05 The Dow Chemical Company Aqueous dispersions of plasticized polymer particles
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US4668517A (en) * 1985-04-04 1987-05-26 Norwich Eaton Pharmaceuticals, Inc. Furazolidone dosage form
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
US6468561B1 (en) * 1986-06-19 2002-10-22 Bpsi Holdings, Inc. Aqueous film coating with improved properties
US5840293A (en) * 1988-11-16 1998-11-24 Advanced Polymer Systems, Inc. Ionic beads for controlled release and adsorption
US5284659A (en) * 1990-03-30 1994-02-08 Cherukuri Subraman R Encapsulated flavor with bioadhesive character in pressed mints and confections
EP0520119A1 (de) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Neue orale Diclofenaczubereitung
JPH0672861A (ja) * 1992-07-09 1994-03-15 Takeda Chem Ind Ltd 着色固形製剤
ES2137862B1 (es) * 1997-07-31 2000-09-16 Intexim S A Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
KR100387245B1 (ko) 1997-10-17 2003-08-19 일양약품주식회사 유산균의안정화를위한미세장용성코팅과립
US6251430B1 (en) * 1998-02-04 2001-06-26 Guohua Zhang Water insoluble polymer based sustained release formulation
KR19990072826A (ko) * 1998-02-26 1999-09-27 우재영 판크레아틴장용코팅과립의제조방법
US6372254B1 (en) 1998-04-02 2002-04-16 Impax Pharmaceuticals Inc. Press coated, pulsatile drug delivery system suitable for oral administration
DE19901686A1 (de) * 1999-01-18 2000-07-20 Gruenenthal Gmbh Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung
JP2001122788A (ja) * 1999-10-22 2001-05-08 Kokandou Seiyaku Kk 医薬用固形組成物
US6420473B1 (en) 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
AU2001261434A1 (en) * 2000-05-11 2001-11-26 Pharmacia Corporation Aldosterone antagonist composition for release during aldosterone acrophase
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US20030031772A1 (en) * 2001-03-28 2003-02-13 Zehner Lee R. Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glyemic index
US6759058B1 (en) 2001-04-25 2004-07-06 Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences Enteric-coated proliposomal formulations for poorly water soluble drugs
CA2461708C (en) * 2001-09-28 2012-08-07 Nutraceutix, Inc. Delivery system for biological component
EP1455751A1 (en) 2001-12-20 2004-09-15 Pharmacia Corporation Zero-order sustained released dosage forms and method of making the same
CN1176653C (zh) * 2002-08-26 2004-11-24 鲁南制药股份有限公司 阿尼西坦缓释胶囊
US6703044B1 (en) 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
KR100570419B1 (ko) * 2004-01-14 2006-04-11 코오롱제약주식회사 염산 탐술로신의 경구 투여용 서방성 펠렛 조성물 및 그제조방법

Also Published As

Publication number Publication date
AU2005231145B2 (en) 2010-10-28
CA2555114A1 (en) 2005-10-20
US20050220878A1 (en) 2005-10-06
MXPA06010488A (es) 2006-12-19
ZA200606744B (en) 2008-02-27
AU2005231145B8 (en) 2010-11-11
WO2005097082A1 (en) 2005-10-20
JP2007530683A (ja) 2007-11-01
EP1729742A1 (en) 2006-12-13
BRPI0508075A (pt) 2007-07-17
CN1938006B (zh) 2010-11-10
US7709025B2 (en) 2010-05-04
CA2555114C (en) 2012-05-29
KR20070007868A (ko) 2007-01-16
AU2005231145A1 (en) 2005-10-20
IL177225A0 (en) 2006-12-10
CN1938006A (zh) 2007-03-28

Similar Documents

Publication Publication Date Title
NO20064983L (no) Enterisk opploselig belegg til oralt inntakbare substrater
WO2005101983A3 (en) Gastric retention system
AR114143A2 (es) Formulaciones de comprimidos revestidos
NO20090346L (no) Pyrazolderivater som inhibitorer av cytokrom P450
NO20052524L (no) Aminerte isofiavonoidderivater og anvendelse derav
AU2003297581A1 (en) Methods, systems and compositions for fire retarding substrates
WO2006063070A3 (en) All surface data for use in substrate inspection
WO2005123277A3 (en) Optical films and methods of making the same
EP2308867A3 (en) 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses
WO2007089881A3 (en) Electrospray coating of objects
WO2005101112A3 (en) Optical films and methods of making the same
DK1940703T3 (da) Anordning til emballering og udlevering af faste formede legemer, specielet til orale tabletter og/eller kapsler
BRPI0719395C1 (pt) tablete revestido de filme
EP1260219A3 (en) Dip coating compositions containing cellulose ethers
MX2008002492A (es) Composiciones farmaceuticas que comprenden un farmaco dependiente del ph, un modificador del ph, y un agente retardante.
WO2008129517A3 (en) A stabilized delayed release pharmaceutical composition of rabeprazole
IL177243A0 (en) Extended release coated minitablets of venlafaxine hydrochloride
WO2007065595A3 (en) Xanthine derivatives, processes for preparing them and their uses
NO20064934L (no) Fremgangsmate for fremstilling av et fast, farmasoytisk preparat
EP1297827A3 (en) Film forming composition comprising sucralose and carrageenan
TW200636521A (en) All surface data for use in substrate inspection
WO2006044077A3 (en) Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
CL2008003230A1 (es) Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta.
DK1181047T4 (da) Sammensætning indeholdende alkalisk sphingomyelase af bakteriel oprindelse til brug som diætært middel, kosttilskud eller farmaceutisk produkt
DK1707564T3 (da) Indanyl-piperazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application